Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Damora Therapeutics, Inc.

Damora Therapeutics, Inc. (GLTO) Stock Overview

Explore Damora Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

GLTO●NASDAQ
HealthcareMedical - Pharmaceuticals
$21.58
$0.75(3.36%)
U.S. Market opens in 11h 45m

Damora Therapeutics, Inc. (GLTO)

Meyka AI Score

Z

Key Financials

Market Cap34.5M
P/E Ratio-0.17
EPS (TTM)$-12.11
ROE-1.22%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 Months$35.05
1 Year Target$25.33

GLTO Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Damora Therapeutics, Inc. (NASDAQ: GLTO) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Damora Therapeutics, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of GLTO on the NASDAQ shows an RSI of 53.67, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $25.33 for the NASDAQ listing.

Key metrics behind Damora Therapeutics, Inc.'s NASDAQ-traded stock include a P/E ratio of -0.17 and a market capitalization of 34.5M. Combined with our AI analysis, these give both institutional and retail investors a clear view of GLTO on the NASDAQ.

Price Performance (NASDAQ: GLTO)

1-Day Change
-28.02%
5-Day Change
-14.91%
1-Month Change
-3.27%
3-Month Change
-12.17%
6-Month Change
-1.10%
Year-to-Date (YTD) Change
-6.21%
1-Year Change
564.00%
3-Year Change
-66.93%
5-Year Change
-81.40%
All-Time (Max) Change
-94.25%

Contact Information

https://damoratx.com
457 070 5210
Building 23, Boston, MA, 02453

Company Facts

70 Employees
IPO DateOct 28, 2020
CountryUS

Frequently Asked Questions